MRA Advisory Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-590
| Closed | -$420K | – | 146 |
|
|
2024
Q4 | $420K | Buy |
590
+157
| +36% | +$112K | 0.22% | 56 |
|
|
2024
Q3 | $455K | Buy |
+433
| New | +$455K | 0.25% | 53 |
|
|
2024
Q1 | – | Sell |
-287
| Closed | -$252K | – | 116 |
|
|
2023
Q4 | $252K | Buy |
+287
| New | +$252K | 0.17% | 74 |
|
|
2021
Q1 | – | Sell |
-689
| Closed | -$333K | – | 113 |
|
|
2020
Q4 | $333K | Buy |
+689
| New | +$333K | 0.33% | 65 |
|